Delivery Order SPE2DB20D3103-SPE2DB23FL5Q5

Award Date 11/8/22
Potential Completion Date 11/9/22
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Norethindrone 5 mg tablets. The contract, valued at $3,484.08, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,085.64 firm fixed-price delivery order is for 4,566,240 units of the drug Norethindrone 5 mg tablets. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,545.30 firm-fixed-price delivery order is for the supply of 90 units of the drug Norethindrone 5 mg Tablet. The contract has an ultimate completion date of October 26, 2023. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,989.22 firm-fixed-price delivery order is for the supply of 90 tablets of Norethindrone 5 mg, a generic medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,045.81 firm fixed-price contract is for the supply of 4,565,237,622 units of the pharmaceutical product Norethindrone 5 mg tablet. The contract has an ultimate completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.83 firm fixed-price contract provides the DLA with 4,557,601,070 units of the medication Norethindrone 5 mg tablets. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $1,834.23 and has an ultimate completion date of November 29, 2023. The contract covers the supply of 4562925701 NORETHINDRONE 5 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.79 firm fixed-price delivery order is for the supply of 4556089076 norethindrone 5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,099.00 Firm Fixed Price delivery order contract is for the supply of 4,559,459,281 units of the pharmaceutical product Norethindrone 5 mg Tablets, in 50-count packages. The contract has an ultimate completion date of December 28, 2022. No set-aside designation was used for this open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,888.16 firm fixed-price delivery order is for the supply of 4,566,759,751 units of the prescription drug Norethindrone 5 mg tablets. The award is not designated as a set-aside contract. The contract is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FL5Q5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,559,036,158 units of Norethindrone 5 mg tablets in 90-count packages. The $1,631.85 firm-fixed-price Delivery Order was awarded on November 8, 2022, with a period of performance through November 9, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC, which runs through December 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award did not utilize any set-aside designations, indicating full and open competition.

Generated 2/27/25, 10:03 AM